New stem cell therapy aims to restore kidney function in early trial

NCT ID NCT07572890

Recruiting now Disease control Sponsor: Adia Med of Winter Park LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment called AdiaVita, made from umbilical cord stem cells, for adults with chronic kidney disease. About 100 people aged 18 to 80 with moderate kidney problems will receive monthly infusions and a daily skin spray for three months. The goal is to see if the treatment safely improves kidney function compared to a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome impaired renal function disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE CHRONIC KIDNEY DISEASE (CKD) CKD KIDNEY DISEASE KIDNEY DISEASE, CHRONIC

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Adia Med Of Winter Park
RECRUITING

Winter Park, Florida, 32789, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.